FDA approves Akebia Therapeutics’ Vafseo for anaemia caused by CKD
The approval is supported by the safety and efficacy data from the INNO2VATE programme and post-marketing safety data…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Mar 24
The approval is supported by the safety and efficacy data from the INNO2VATE programme and post-marketing safety data…
28 Mar 24
Chubb today announced the launch of a new HealthTech industry practice in the UK.
28 Mar 24
Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company,…
28 Mar 24
Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, and Springer…
28 Mar 24
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced a significant expansion of their Bristol, PA bioconjugate…
27 Mar 24
The FDA approval, following the US FDA Breakthrough Therapy Designation, is based on the results from the Phase…
27 Mar 24
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the release of the QIAstat-Dx Analyzer 2.0, including the…
26 Mar 24
Cardior is engaged in the discovery and development of therapies that prevent, repair and reverse diseases of the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Mar 24
According to the terms of the agreement, Ferrer will gain the exclusive rights to co-develop and market VRG50635…
26 Mar 24
The acquisition is expected to advance Nuvation Bio as a late-stage, international oncology firm in which its current…